Articles related to SLEEP MEDICINE

“Essentially, we found that stimulants pre-reward our brains and allow us to keep working at things that wouldn’t normally hold our interest.” – Dr. Nico Dosenbach, Washington University School of Medicine

Studies have shown a mean effect size with CBTI of 0.96 compared with 0.87 for pharmacotherapy, suggesting similar efficacy in short term but CBTI seems to have longer-lasting effects.

The body doesn’t develop a physical dependence on magnesium, meaning if your patients stop taking it, they won’t go through withdrawal or experience real physiological cravings.

Melatonin supplements are widely thought of as a safe and ‘natural’ option to support better sleep, so it was striking to see such consistent and significant increases in serious health outcomes, even after balancing for many other risk factors.

68% of participants in the amitriptyline group reported worsening sleep following discontinuation, with only 12% describing this as temporary.

“With two large phase 3 studies now demonstrating a consistent and significant efficacy profile for AD109, we are closer to delivering the first oral pharmacotherapy for over 80 million US adults with OSA.”